title: Twenty-year follow-up of a randomized trial comparing intraosseous and i.v. BM transplantation.
authors.affiliation: Haematology Centre, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
authors.forename: H
authors.initials: H
authors.lastname: Hägglund
authors.affiliation: 1] Division of Therapeutic Immunology, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden [2] Centre for Allogeneic Stem Cell Transplantation (CAST), Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
authors.forename: M
authors.initials: M
authors.lastname: Remberger
authors.affiliation: 1] Division of Therapeutic Immunology, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden [2] Centre for Allogeneic Stem Cell Transplantation (CAST), Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
authors.forename: O
authors.initials: O
authors.lastname: Ringden
mesh_terms: D000906:Antibodies / Q000737:chemistry; D016026:Bone Marrow Transplantation / Q000379:methods*; D005500:Follow-Up Studies; D006085:Graft Survival; D006086:Graft vs Host Disease / Q000276:immunology*; D018380:Hematopoietic Stem Cell Transplantation / Q000379:methods*; D006801:Humans; D015994:Incidence; D009504:Neutrophils / Q000166:cytology; D011336:Probability; D012008:Recurrence; D019172:Transplantation Conditioning; D014184:Transplantation, Homologous; D016896:Treatment Outcome
chemical_list: D000906:Antibodies